NLS

After close to ten years as CEO, Annette Säfholm has decided to step down from her role. The Board of Directors has appointed Julie Waras Brogren as the new Chief Executive Officer.

This investment will expand medicines manufacturing and R&D in China and leverage the country’s scientific excellence, advanced manufacturing, and China-UK healthcare ecosystem collaborations.

For the first time, Sweden’s MAX IV synchrotron will welcome an artist in residence.

Alvotech has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea 2mg, which is approved for marketing in the European Economic Area, United Kingdom and Japan.

“Claus has a strong track record of building and scaling health-focused businesses, combining strategic clarity with deep customer and market insight. His experience across regulated health products, international commercialization, and partnership-driven growth makes him exceptionally well suited to lead Sigrid into its next phase. I would also like to thank Sana Alajmovic for building the […]

The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded a new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).